Literature DB >> 25317899

[Multidrug-resistant germs in neurological early rehabilitation (2004-2013)].

J D Rollnik1, A-M Samady2, L Grüter2.   

Abstract

Multidrug-resistant germs are an increasing problem in neurological and neurosurgical early rehabilitation but reliable data is missing. The present study examined the prevalence of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and multidrug-resistant gram negative germs (MRGN) in a German neurological early rehabilitation facility (BDH Clinic Hessisch Oldendorf). Observation period was 2004-2013 (10 years). MRSA prevalence on admission was 11.4%, MRGN prevalence during rehabilitation 11.8%. A combination of different multidrug-resistant germs (MRSA plus MRGN) was observed in 3.8% of all cases. VRE were first detected in 2009, prevalence was as low as 0.1%. High prevalence of MRSA and MRGN raises major financial, medical, and ethical problems in early rehabilitation facilities. The authors encourage further multi-center studies and suggest a better recompense for this group of patients in the German DRG-system (Diagnosis Related Groups). © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2014        PMID: 25317899     DOI: 10.1055/s-0034-1375640

Source DB:  PubMed          Journal:  Rehabilitation (Stuttg)        ISSN: 0034-3536            Impact factor:   1.113


  5 in total

Review 1.  [Prolonged weaning during early neurological and neurosurgical rehabilitation : S2k guideline published by the Weaning Committee of the German Neurorehabilitation Society (DGNR)].

Authors:  J D Rollnik; J Adolphsen; J Bauer; M Bertram; J Brocke; C Dohmen; E Donauer; M Hartwich; M D Heidler; V Huge; S Klarmann; S Lorenzl; M Lück; M Mertl-Rötzer; T Mokrusch; D A Nowak; T Platz; L Riechmann; F Schlachetzki; A von Helden; C W Wallesch; D Zergiebel; M Pohl
Journal:  Nervenarzt       Date:  2017-06       Impact factor: 1.214

2.  Critical illness polyneuropathy (CIP) in neurological early rehabilitation: clinical and neurophysiological features.

Authors:  Simone B Schmidt; Jens D Rollnik
Journal:  BMC Neurol       Date:  2016-12-15       Impact factor: 2.474

3.  Outcome of neurological early rehabilitation patients carrying multi-drug resistant bacteria: results from a German multi-center study.

Authors:  J D Rollnik; M Bertram; C Bucka; M Hartwich; M Jöbges; G Ketter; B Leineweber; M Mertl-Rötzer; D A Nowak; T Platz; K Scheidtmann; R Thomas; F von Rosen; C W Wallesch; H Woldag; P Peschel; J Mehrholz; M Pohl
Journal:  BMC Neurol       Date:  2017-03-20       Impact factor: 2.474

4.  Impact of healthcare-associated infections on functional outcome of severe acquired brain injury during inpatient rehabilitation.

Authors:  Michelangelo Bartolo; Chiara Zucchella; Hend Aabid; Beatrice Valoriani; Massimiliano Copetti; Andrea Fontana; Domenico Intiso; Mauro Mancuso
Journal:  Sci Rep       Date:  2022-03-28       Impact factor: 4.379

5.  Patients with Rheumatic Diseases do not have an Increased Risk of MRSA Carrier Status.

Authors:  Judith Krämer; Konstantinos Triantafyllias; Wolfgang Kohnen; Martin Leber; Ute Dederichs-Masius; Andrea Zucker; Jürgen Körber; Andreas Schwarting
Journal:  Rheumatol Ther       Date:  2018-06-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.